Boulder biotech co. enters technology-share agreement with industry giant
Boulder-based SomaLogic has an agreement with biotech giant Amgen (Nasdaq: AMGN) to use some of SomaLogic ’s proprietary technology to help advance Amgen’s drug discovery and development programs.
The agreement builds upon an existing collaboration SomaLogic has with an Amgen subsidiary, Iceland-based deCODE. The new agreement will expand to broader application across Amgen’s pipeline.
SomaLog ic specializes in diagnostic tests that can deliver actionable health-management information for…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jensen Werley Source Type: news